Asia Health Check-ups Market To Reach $20.47 Billion By 2030

Asia Health Check-ups Market Growth & Trends

The Asia health check-ups market size is expected to reach USD 20.47 billion by 2030, expanding at a CAGR of 6.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth is largely attributable to the increasing prevalence of non-communicable and communicable diseases, growing investments from government & private organizations to detect diseases at early stages, and the adoption of technologically advanced testing products across various healthcare platforms.

The increasing elderly population in Asia is leading to a rise in demand for health check-ups. As people age, they become more susceptible to chronic illnesses that require regular monitoring & preventive care. For example, Vietnam is aging rapidly due to declining fertility rates and increasing life expectancy. As a result, Vietnam is currently one of the fastest-aging countries in the world, with adults aged 60 and above expected to represent more than a quarter of the population by 2045, up from 12% in 2020. In 2020, 1 in 6 people in Singapore are now aged 65 and above, which is expected to further increase to 1 in 4 by 2030. Hence, the health check-up industry is expected to witness lucrative growth in the coming years.

Increasing government initiatives to improve the healthcare facilities in Asia region, especially in developing countries are expected to increase the market uptake. For instance, in February 2022, the WHO and the Indian Council of Medical Research collaborated to expand the number of laboratories performing serological and molecular testing for different infectious diseases in India. Moreover, the adoption of well-established laboratory-based surveillance (LBS) in developing countries in the Asia region can reduce the target disease burden in the region.

Moreover, key players operating in the Asia health check-up industry are focusing on different forms of strategic initiatives, such as mergers and acquisitions, to increase their respective shares in the market. For instance, in February 2022, Eurofins Scientific acquired Genetic Testing Service JSC in Vietnam. The acquisition strengthened Eurofins' presence in Asia and added to its international network of clinical diagnostics facilities that specialize in cutting-edge genetic testing.

Similarly, in April 2023, ARUP Laboratories entered into a strategic collaboration with Gestalt Diagnostics Inc. Under this collaboration, ARUP Laboratories decided to use PathFlow Solution from Gestalt for Strategic Digital Projects.

 Request a free sample copy or view report summary: Asia Health Check-Ups Market Report

Asia Health Check-Ups Market Report Highlights

• The general health check-up segment held the largest revenue share in 2022, attributable to the high use of testing services to identify critical medical issues

• The blood glucose test segment of the market held the largest share in 2022, owing to the high prevalence of diabetes and rapid growth in the geriatric population

• The cardiovascular diseases segment dominated the market in 2022 owing to increasing disease prevalence coupled with high mortality rates and advancements in testing products

• Hospital-based laboratories held the largest revenue share in 2022 owing to the increasing number of hospitals integrating laboratories into their premises along with the ability to provide prompt & precise reports

• Individuals segment of the market captured the largest revenue share in 2022 due to increasing awareness about general health check-ups along with the introduction of offers from market players

• China led the regional market in 2022, which can be attributed to the large population base and high prevalence of chronic disorders

Asia Health Check-Ups Market Segmentation

For the purpose of this report, Grand View Research has segmented the Asia health check-up market based on type, test type, application, service provider, end-use, and country:

Asia Health Check-Up Type Outlook (Revenue, USD Billion, 2018 - 2030)

• General Health Check-up

• Preventive Health Check-up

• Specialized Health Check-up

• Routine and Wellness Health Check-up

Asia Health Check-Up Test Type Outlook (Revenue, USD Million, 2018 - 2030)

• Blood Glucose Test

• Kidney Function Test

• Bone Profile Test

• Electrolyte Test

• Liver Function Test

• Lipid Profile Test

• Special Biochemistry

• Cardiac Biomarkers

• Hormones & Vitamins

• Tumor Markers

• Others

Asia Health Check-Up Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiovascular Diseases

• Metabolic Disorders

• Cancer

• Inflammatory Conditions

• Musculoskeletal Disorders

• Neurological Conditions

• Others

Asia Health Check-Up Service Provider Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital-Based Laboratories

• Central Laboratories

• Standalone Laboratories

Asia Health Check-Up End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Enterprise

• Individuals

Asia Health Check-Up Country Outlook (Revenue, USD Million, 2018 - 2030)

• Japan

• China

• India

• South Korea

• Thailand

• Singapore

• Indonesia

• Malaysia

• Vietnam

List of Key Players in the Asia Health Check-Up Market

• Eurofins Scientific

• SYNLAB International GmbH

• UNILABS

• OPKO Health, Inc. (BioReference Health, LLC.)

• Sonic Healthcare Limited

• ARUP Laboratories

• Q2 Solutions

• Laboratory Corporation of America Holdings

• LalPathLabs.com.

• Quest Diagnostics Incorporated